- Report
- November 2025
- 185 Pages
Global
From €4172EUR$4,500USD£3,490GBP
- Report
- January 2026
- 196 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- January 2026
- 181 Pages
Global
From €4172EUR$4,500USD£3,490GBP
- Report
- November 2026
- 468 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- July 2026
- 160 Pages
Global
From €3078EUR$3,320USD£2,575GBP
€3848EUR$4,150USD£3,218GBP
- Report
- October 2026
- 367 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- October 2026
- 327 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- July 2026
- 265 Pages
Global
From €3848EUR$4,150USD£3,218GBP
- Report
- June 2026
- 150 Pages
Global
From €5516EUR$5,950USD£4,614GBP
- Report
- May 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- May 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- May 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- March 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP

Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research.
Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more